ClinicalTrials.gov
ClinicalTrials.gov Menu

Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00005984
Recruitment Status : Terminated (Study terminated as principal investigator [PI] left the university.)
First Posted : January 27, 2003
Last Update Posted : November 29, 2017
Sponsor:
Information provided by:
Masonic Cancer Center, University of Minnesota

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : September 2005
  Actual Study Completion Date : September 2005